School of Medicine
Showing 201-300 of 584 Results
-
Matthew F. Reeves
Adjunct Clinical Associate Professor, Obstetrics & Gynecology
BioDr. Matthew Reeves is the Executive Director and founder of the DuPont Clinic, a center providing patient-centered abortion care in all trimesters. With the team at the DuPont Clinic, Dr. Reeves has worked to re-envision the patient experience, create a new patient flow without a waiting room, develop new shortened protocols for later abortion, improve nurse-administered moderate sedation techniques, and introduce new and redesigned gynecologic instruments. Dr. Reeves also serves on the board of directors of DKT International, a social marketing organization that provided over 44 million couple-years of contraception in over 25 countries and is now the sole distributor for Ipas aspirators and Sino-Implant II. Previously, he was Medical Director of the National Abortion Federation where he worked to improve the quality of abortion care across North and South America. From 2010-2014, Dr. Reeves was the Chief Medical Officer of WomanCare Global where his work focused on expanding use of manual uterine aspiration and introducing mifepristone and levonorgestrel implants to new markets. Throughout his career, Dr. Reeves has worked on clinical research, primarily in the areas of post-abortal intrauterine contraception and improvements in abortion service delivery. In addition to this appointment at Stanford, he currently has an appointment as an Adjunct Associate Professor at the Johns Hopkins Bloomberg School of Public Health. Dr. Reeves attended Harvard Medical School and completed residency in obstetrics & gynecology at the University of California, San Francisco (UCSF). He then completed the fellowship in Clinical Ultrasound at UCSF followed by the Fellowship in Family Planning at the University of Pittsburgh.
-
Donald Regula, MD
Professor (Teaching) of Pathology, Emeritus
BioDr. Regula was the course director for the required medical student course, Science of Medicine, and previously the course director of the required pathology course (1993-2020)
He was the Director of the Stanford Autopsy Service (1995-2021)
He is the faculty co-lead for the EPIC Beaker-AP implementation project. -
David Rehkopf
Professor of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Pediatrics, of Health Policy and of Sociology
BioI am a social epidemiologist and serve as a Professor in the Department of Epidemiology and Population Health and in the Department of Medicine in the Division of Primary Care and Population Health. I joined the faculty at Stanford School of Medicine in 2011.
I am Director of the Stanford Center for Population Health Sciences. In this position, I am committed to making high-value data resources available to researchers across disciplines in order to better enable them to answer their most pressing clinical and population health questions.
My own research is focused on understanding the health implications of the myriad decisions that are made by corporations and governments every day - decisions that profoundly shape the social and economic worlds in which we live and work. While these changes are often invisible to us on a daily basis, these seemingly minor actions and decisions form structural nudges that can create better or worse health at a population level. My work demonstrates the health implications of corporate and governmental decisions that can give the public and policy makers evidence to support new strategies for promoting health and well-being. In all of his work, I have a focus on the implications of these exposures for health inequalities.
Since often policy and programmatic changes can take decades to influence health, my work also includes more basic research in understanding biological signals that may act as early warning signs of systemic disease, in particular accelerated aging. I examine how social and economic policy changes influence a range of early markers of disease and aging, with a particular recent focus on DNA methylation. I am supported by several grants from the National Institute on Aging and the National Institute on Minority Health and Health Disparities to develop new more sensitive ways to understand the health implications of social and economic policy changes. -
James H Reich
Adjunct Professor, Psych/General Psychiatry and Psychology (Adult)
BioI attended U.C. Berkeley for my B.S. degree, the University of Colorado for my MD and U.C. Davis for my psychiatric residency and did a fellowship in Psychiatric Epidemiology at Yale. I have been faculty at the University of Iowa, Harvard and Brown. I have published over a hundred papers in peer reviewed journals, mostly in the areas of anxiety and personality. I also founded a medical society, the Association for Research in Personality Disorders (ARPD).
Currently I am in private practice in San Francisco and teach at Stanford and UCSF. My treatment approaches for psychotherapy include CBT and mindfulness. I also do psychopharmacology which I have taught UCSF for many years.
I am also a board certified forensic psychiatrist in private practice focusing largely on civil cases. -
Daryn Reicherter
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Reicherter the director of the Human Rights in Trauma Mental Health Laboratory.
He has expertise in the area of cross-cultural trauma psychiatry, having spent more than a decade dedicated to providing a combination of administrative and clinical services in trauma mental health locally and internationally. He is on the List of Experts for the Extraordinary Chambers in the Courts of Cambodia and for the United Nations’ International Criminal Court. He is on the Fulbright Specialists Roster for his work in international trauma mental health. He is a Senior Fellow at the Center for Innovations in Global Health at Stanford University. He has created and cultivated new clinical rotations for residency education and medical school education in the community clinics that he operates. And he has created new opportunities for resident, medical student, and undergraduate education in Global Mental Health.
He has also been involved in the creation of clinical mental health programs for underserved populations in the San Francisco Bay Area. He is the Faculty Adviser for the Stanford’s Free Clinic Mental Health Program.
After receiving degrees in Psychobiology and Philosophy from the University of California at Santa Cruz, Dr. Reicherter completed his doctorate in medicine at New York Medical College. He completed internship and residency and served as Chief Resident at Stanford University Hospitals and Clinics. -
Richard J. Reimer, MD
Professor of Neurology and Neurological Sciences (Adult Neurology)
Current Research and Scholarly InterestsReimer Lab interests
A primary interest of our lab is to understand how nerve cells make and recycle neurotransmitters, the small molecules that they use to communicate with each other. In better defining these processes we hope to achieve our long-term goal of identifying novel sites for treatment of diseases such as epilepsy and Parkinson Disease. In our studies on neurotransmitter metabolism we have focused our efforts on transporters, a functional class of proteins that move neurotransmitters and other small molecules across membranes in cells. Transporters have many characteristics that make them excellent pharmacological targets, and not surprisingly some of the most effective treatments for neuropsychiatric disorders are directed at transporters. We are specifically focusing on two groups of transporters vesicular neurotransmitter transporters that package neurotransmitters into vesicles for release, and glutamine transporters that shuttle glutamine, a precursor for two major neurotransmitters glutamate and GABA, to neurons from glia, the supporting cells that surround them. We are pursuing these goals through molecular and biochemical studies, and, in collaboration with the Huguenard and Prince labs, through physiological and biosensor based imaging studies to better understand how pharmacological targeting of these molecules will influence neurological disorders.
A second interest of our lab is to define mechanism underlying the pathology of lysosomal storage disorders. Lysosomes are membrane bound acidic intracellular organelles filled with hydrolytic enzymes that normally function as recycling centers within cells by breaking down damaged cellular macromolecules. Several degenerative diseases designated as lysosomal storage disorders (LSDs) are associated with the accumulation of material within lysosomes. Tay-Sachs disease, Neimann-Pick disease and Gaucher disease are some of the more common LSDs. For reasons that remain incompletely understood, these diseases often affect the nervous system out of proportion to other organs. As a model for LSDs we are studying the lysosomal free sialic acid storage disorders. These diseases are the result of a defect in transport of sialic acid across lysosomal membranes and are associated with mutations in the gene encoding the sialic acid transporter sialin. We are using molecular, genetic and biochemical approaches to better define the normal function of sialin and to determine how loss of sialin function leads to neurodevelopmental defects and neurodegeneration associated with the lysosomal free sialic acid storage disorders. -
Navi Reiners, MD, MPH
Adjunct Clinical Assistant Professor, Obstetrics & Gynecology - General
BioDr. Navi Reiners is board certified in Obstetrics and Gynecology. She is dedicated to providing comprehensive obstetrical and gynecological care to women of all ages in a compassionate and patient-centered manner. Her clinical interests include health education and wellness, pregnancy, adolescent health, contraception and minimally invasive surgery. When she is not taking care of patients, she enjoys reading, baking, Pilates and exploring her native Bay Area with her husband and young children.
-
Olaf Reinhartz
Clinical Associate Professor, Cardiothoracic Surgery
Current Research and Scholarly Interests1. Mechanical circulatory support in failing Fontan circulation
2. Pathophysiologic response to fetal cardiac surgery.
3. Various clinical projects in pediatric cardiothoracic surgery -
Eduardo Pontes Reis
Affiliate, Rad/Integrative Biomedical Imaging Informatics at Stanford
BioI'm a visiting scholar at Stanford AIMI Center, working in the intersection of Artificial Intelligence and Medicine. My purpose is to contribute to our understanding of intelligence. And our best chance to achieve this is through AI.
Research highlights:
- Published BRAX, the Brazilian Chest X-ray Dataset - https://www.nature.com/articles/s41597-022-01608-8
- Open-sourced the PyTorch implementation of ConVIRT (Y Zhang et al), a contrastive learning method for radiologic images and text (before CLIP) - https://github.com/edreisMD/ConVIRT-pytorch
- Released Brain Hemorrhage Annotations - Brain Hemorrhage Extended - BHX (https://physionet.org/content/bhx-brain-bounding-box)
At Hospital Israelita Albert Einstein:
- Started the Health Story project, a medical history timeline to support research and a more personalized clinical practice
- Ran the development of AI algorithms for diseases of national importance: Tuberculosis, COVID, Melanoma and Head CT -
Allan L. Reiss
Howard C. Robbins Professor of Psychiatry and Behavioral Sciences and Professor of Radiology
Current Research and Scholarly InterestsMy laboratory, the Center for Interdisciplinary Brain Sciences Research (CIBSR), focuses on multi-level scientific study of individuals with typical and atypical brain structure and function. Data are obtained from genetic analyses, structural and functional neuroimaging studies, assessment of endocrinological status, neurobehavioral assessment, and analysis of pertinent environmental factors. Our overarching focus is to model how brain disorders arise and to develop disease-specific treatments.
-
Marissa Reitsma
Assistant Professor of Health Policy
BioMarissa Reitsma, PhD, is an Assistant Professor of Health Policy at Stanford University School of Medicine. She obtained her PhD in Health Policy at Stanford in 2024, during which time she was a Knight-Hennessy Scholar, Stanford Data Science Scholar, and NSF Graduate Research Fellow. Previously, she worked on the Global Burden of Disease Study at the Institute for Health Metrics and Evaluation. Reitsma develops computational models to quantify disease burden, evaluate the benefits and costs of interventions, and support evidence-based policies across a range of priorities in public health, with a focus on health equity.
Reitsma aims to build simulation models that integrate the overlapping risk factors, social determinants, and syndemic conditions that disproportionately impact marginalized populations and contribute to health inequities. She also investigates the potential for multimodal data synthesis to inform these models, improve population health decision-making, and reduce health disparities. Her work spans multiple communicable and non-communicable conditions linked to behavioral risk factors, including tobacco use, drug use, and obesity. During the COVID-19 pandemic, she collaborated closely with state and local public health agencies to inform their decision-making. -
Bruce A Reitz
Norman E. Shumway Professor, Emeritus
Current Research and Scholarly InterestsMechanism of allograft rejection for the heart and, lung; late chronic effects of rejection, such as graft coronary, atherosclerosis in the heart and bronchiolitis obliterans in the, lung; treatment of rejection, including pharmacologic agents, total, lymphoid irradiation, and the induction of tolerance in fetal, animals; clinical studies include the results of lung and heart-lung, transplantation, modification of immunosuppressive protocols, and, factors contributing to late chronic rejection.
-
David A. Relman
Thomas C. and Joan M. Merigan Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsMy investigative program focuses on human-microbe interactions and human microbial ecology, and primarily concerns the ecology of human indigenous microbial communities; a secondary interest concerns the classification of humans with systemic infectious diseases, based on features of genome-wide gene transcript abundance patterns and pther aspects of the host response.
-
Cybele A. Renault, MD, DTM&H, FIDSA
Clinical Associate Professor, Medicine - Infectious Diseases
BioDr. Renault has devoted her career to caring for vulnerable patient populations, both domestically and overseas. She completed her medical school and residency training at the University of Chicago, caring for underserved patients on Chicago's South Side, followed by a Chief Resident year at John H. Stroger, Jr. Hospital of Cook County, the public hospital serving the uninsured in Chicago. She began her career in global health as an Infectious Diseases fellow at Stanford, validating low-cost HIV diagnostics in Burkina Faso, and providing clinical service and teaching in India and Zimbabwe as a fellow, and later in Thailand, Uganda, Rwanda and Kenya as one of our Infectious Diseases faculty. Her clinical work is focused on caring for our veteran population, working to empower veterans to engage in their care, often in the setting of significant mental illness.
Dr. Renault is most passionate about medical education and program development to combat global antimicrobial resistance through antimicrobial stewardship, to create opportunities for the Internal Medicine residents centering on caring for vulnerable patient populations, and to develop impactful and sustainable programs in collaboration with our low- and middle-income partners for our Center for Innovation in Global Health. She served as Associate Program Director for the Internal Medicine Residency Program for 4 years prior to transitioning to her current role as Program Lead for Global Health, for which she leads the Global Health Track for the Internal Medicine residency program and develops global health initiatives for the Department of Medicine. She co-founded and has been director of the Stanford 2-week intensive global health course since its inception in 2012, she has structured trainee and faculty rotations based on evolving needs of our partner sites in Uganda, Rwanda, Zimbabwe, and Sri Lanka, she is the faculty lead for the ID/antimicrobial stewardship partnership between Stanford and Moi Teaching and Referral Hospital in Eldoret, Kenya through the AMPATH Consortium, and she is leading Stanford's Internal Medicine virtual case-based education initiative to support our newest medical school partner in Negele Arsi, Ethiopia.
Dr. Renault strives to augment Stanford's contributions and support for underserved patient populations in the United States. She established resident rotations in Shiprock, New Mexico and Chinle, Arizona through the Indian Health Service, and she is Faculty Advisor for the Internal Medicine Health Equity, Advocacy and Research concentration in the residency program. She also aspires to improve resources for women physicians. In 2016, Dr. Renault established the GME Women in Medicine Leadership Council, with the intention of creating community and encouraging conversations about professional and personal life decisions as women in the field of medicine. She is passionate about mentoring through sharing personal experiences, creating an environment that encourages reflection, and building skills to address challenges unique to women in medicine.
In 2022, in recognition of her passion for medical education and her success in program development, Dr. Renault was asked to join the leadership at Palo Alto Veterans Health Care System as Deputy Associate Chief of Staff for Education. In this role, she works with rotation directors to optimize their respective rotations to offer robust educational opportunities for trainees across specialties who are rotating at the Palo Alto VA. -
Mara Rendi, MD, PhD
Clinical Professor, Pathology
BioDr. Rendi is a breast and gynecologic pathologist with a focus on the education of medical students, residents, and practicing pathologists. Her areas of interest include the utilization of molecular testing in breast cancer, management of high-risk lesions, ancillary testing to aid in the use of novel therapeutics, and development and delivery of effective pathology education to medical students. She is a nationally and internationally known medical educator having won multiple teaching awards for her innovative strategies in pathology education. She is actively involved in undergraduate medical education, resident education, and continuing medical education for practicing pathologists as well as a practicing breast and gynecologic pathologist.
-
Kavita Renduchintala
Clinical Assistant Professor, Medicine
BioKavita Renduchintala, MD is a Clinical Assistant Professor in the Division of Hospital Medicine at Stanford University School of Medicine. She earned her medical degree from the Keck School of Medicine of the University of Southern California (USC) and completed her residency training in Internal Medicine at LAC + USC Medicine Center in Los Angeles.
Dr. Renduchintala’s clinical background includes caring for hospitalized patients across a range of internal medicine settings. Before joining Stanford, she worked at the University of Chicago, where she provided both general medicine and oncologic hospitalist care. She has also held roles in oncologic hospitalist medicine at Moffitt Cancer Center and in surgical co-management at Keck Hospital of USC.
Her academic interests focus on medical education, with a particular focus on transitions that occur during medical training. She is dedicated to supporting trainees and enhancing the learning environment in academic hospital medicine. Her research has also explored vaccine uptake among cancer survivors. -
Zachary T Renfro
MD Student with Scholarly Concentration in Clinical Research / Immunology, expected graduation Spring 2026
Masters Student in Epidemiology and Clinical Research, admitted Autumn 2023BioZachary studied biology at the University of Arkansas where he researched the impact of temperature on macrophage cytokine production across animal species as well as the neural basis of saccadic mislocalization. After graduation, he worked at the Arkansas Department of Health where he developed and implemented Arkansas' first plan to eliminate tuberculosis. Additionally he researched the contribution of epigenetic regulation on the susceptibility, development, and maintenance of chronic pain at the University of Arkansas for Medical Sciences and participated in the front line response to the COVID-19 pandemic.
At Stanford, he is enrolled in the MD and MS in epidemiology and clinical research programs. His current research interests include emerging infectious diseases, immunological response to infection, queer health broadly and queer sexual health specifically. -
Nathan Reticker-Flynn, PhD
Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly InterestsTo metastasize throughout our bodies, tumors subvert and co-opt our immune systems. Our lab seeks to uncover how these processes occur and develops therapies to put a stop to them.
-
Samantha Reyes
Ph.D. Student in Biomedical Physics, admitted Autumn 2022
BioResearch Interests: Preclinical and clinical PET imaging, novel tracer validation in vivo, B cell role in multiple sclerosis and pharmacokinetic modelling
Samantha is a Biomedical Physics PhD student with extensive experience in multi-modal molecular imaging of neurological diseases and a strong background in synthetic chemistry. She helped validate both a novel sigma-1 radiotracer, [18F]FTC-146, for its ability to detect molecular markers of neuropathic pain non-invasively and a [64Cu]hCD19-mAb radiotracer for imaging therapy-induced B cell depletion. She is well-versed in pharmacokinetic modeling, receptor occupancy studies, autoradiography, and cell-based assays. Moreover, is an expert in PET/MR imaging of neonatal mice. -
Andrew Rezvani, M.D.
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsClinical research in allogeneic hematopoietic cell transplantation
-
James H Rhee
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Rhee is a physiatrist and a clinical assistant professor of physical medicine and rehabilitation. For patients with spine and musculoskeletal conditions, he focuses on providing exceptional care emphasizing minimally invasive solutions designed to optimize symptom managementand patient function.
Building on his background in engineering and on his specialized medical training and experience, Dr. Rhee welcomes opportunities to combine medical, mechanical, and interpersonal approaches to the diagnosis and treatment of each patient. He offers a full range of treatment modalities, including epidural steroid injection procedures, sacroiliac and facet joint injections, trigger point and soft tissue injections, orthopedic joint injections, and more. He also provides medial branch blocks and radiofrequency ablations, and performs electrodiagnostic studies.
Among the wide range of conditions that Dr. Rhee treats are bursitis, herniated discs, radiculopathy, sciatica, spinal stenosis, spondylolisthesis, and spondylosis. He also has treated many forms of joint and muscle pain: facet joint, back, neck, hip, and sacroiliac joint pain.
Dr. Rhee’s experience encompasses short-term and long-term care for both acute and chronic conditions, including musculoskeletal injuries, spinal problems, mixed spine-neck and spine-shoulder disorders, and peripheral damage. Many of the cases he treats are injury-related, while a significant number of others are associated with aging. Another portion of his patient population presents with conditions stemming from developmental anomalies.
Prior to joining Stanford Health Care, Dr. Rhee was in private practice in the Bay Area. Previously, he also served in the US Army as a troop medical clinic officer-in-charge and as a brigade surgeon.
Dr. Rhee is board certified by the American Board of Physical Medicine and Rehabilitation. He is a fellow of the American Academy of Physical Medicine and Rehabilitation and a member of the American Society of Interventional Pain Physicians, North American Spine Society, and Spine Intervention Society. -
William Rhine
Professor of Pediatrics (Neonatology), Emeritus
Current Research and Scholarly InterestsNeonatology, extracorporeal membrane oxygenation, nitric oxide therapy, mechanisms of bilirubin toxicity and brain injury, non-invasive biotechnologies to study cellular and organ metabolism.
-
Fauzia Riaz, MD, MHS
Assistant Professor of Medicine (Oncology)
BioDr. Riaz is dedicated to advancing breast cancer treatment through an innovative clinical trial program that focuses on cutting-edge therapeutics and biomarkers.
Dr. Riaz is studying circulating tumor (ct)DNA-minimal residual disease (MRD) as a pivotal biomarker for early-stage breast cancer. She aims to enhance its use in surveillance and early detection while guiding personalized treatment strategies through novel clinical trials. Furthermore, she is committed to improving immunotherapy efficacy by modifying the tumor microenvironment. Her research involves developing early-phase trials that integrate novel therapeutic approaches, combining immunotherapy and radiotherapy. As a Clinical Assistant Professor at Stanford University School of Medicine, Dr. Riaz is also committed to improving the accessibility of cutting edge therapies to all patients. She is leading a collaborative effort with multiple institutions to develop databases that track patient outcomes and inform treatment practices.
Dr. Riaz’s overarching goal is to expand early-phase clinical trials and foster academic-industry partnerships to advance the field of breast oncology and improve patient care. -
Anthony J. Ricci, PhD
Edward C. and Amy H. Sewall Professor in the School of Medicine and Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy of Molecular and Cellular Physiology
Current Research and Scholarly InterestsWe study hearing from biophysical, molecular and signal processing perspectives. One focus is mechanotransduction, where sound is converted into an electrical signal. As a major site for dysfunction, a more detailed understand will provide a means toward intervention. We develop new antibiotics to limit ototoxicity. We investigate drug delivery methods from surgical approaches to slow release systems, including gene therapy tools. We are studying cognitive decline following hearing loss.
-
Brian Travis Rice
Clinical Associate Professor, Emergency Medicine
Current Research and Scholarly InterestsDeveloping data-driven approaches to defining and comparing chief complaints fro emergency and unscheduled acute care in low- and middle-income countries
-
Tia Rich, PhD
Director, Contemplation by Design, Med/SPRC - Division
Current Role at StanfordLecturer, School of Medicine, Community Health and Prevention Research
Director, Stanford Contemplation by Design -
Joshua Richards
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Richards is board certified in Orthopedic Surgery and has a Certified Additional Qualification for Hand and Upper Extremity Surgery. For over 15 years he has specialized in the treatment of ligamentous, joint, tendon, nerve and bone injuries of the Hand, Elbow, Wrist and Shoulder.
He has served the Bay Area community as a UCSF Assistant Professor as a volunteer educator at San Francisco General Hospital, by teaching and treating complex trauma at the Alameda County Level One Trauma Center-Highland Hospital, and through various volunteer roles on athletic fields around the Bay.
Dr. Richards obtained his Bachelors Degree in Neurobiology at Cornell University, his Masters of Public Health at the Columbia University, and his Medical Degree at New York Medical College.
He completed his residency in orthopedic surgery at the San Francisco Orthopedic Residency Program. He then returned to Cornell University’s Hospital for Special Surgery to complete his fellowship training in hand, upper extremity, and microvascular surgery.
Until joining Stanford in 2023, he had been in private practice in the East Bay since 2006. He has volunteered locally in a variety of organizations and internationally on several continents. -
Jenae Aesha Richardson
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Jenae Richardson is a Clinical Assistant Professor and a CA Licensed Clinical Psychologist in the INSPIRE Clinic in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She also works in the acute psychiatric inpatient units at Stanford Hospital. She specializes in utilizing evidence-based treatments (EBTs) to treat individuals with psychosis and has worked with this population across inpatient and outpatient settings. She is passionate about improving the dissemination and implementation of Cognitive Behavioral Therapy for psychosis (CBTp), and at the INSPIRE Clinic, she leads CBTp trainings for mental health professionals and provides CBTp to individuals with psychosis. Dr. Richardson completed her pre-doctoral internship at the University of Arizona’s Early Psychosis Intervention Center and her postdoctoral fellowship at Veterans Affairs Palo Alto Health Care System. She obtained her doctorate in clinical psychology from Long Island University Post and conducted research exploring barriers to implementing CBTp in the United States.
-
Pema Richeson
Research Program Manager, Pathology - Montine Lab
Current Role at StanfordProgram Manager | Team eDyNAmiC, Cancer Grand Challenges
Project Manager | PPMI Pathology Core -
Stephen Richmond
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Stephen Richmond is a family physician, educator, and health justice advocate with specific interest in racial equity in medicine. He currently serves as a clinical assistant professor of medicine in the Division of Primary Care & Population Health (PCPH) in the Stanford Department of Medicine. He completed his A.S. at Solano Community College, B.A. in Molecular & Cell Biology at UC Berkeley, M.P.H. at Harvard T.H. Chan School of Public Health, and his M.D. at David Geffen School of Medicine, UCLA. He is a graduate of the UCSF-San Francisco General Hospital Family & Community Medicine Residency Program. As a clinician, Dr. Richmond cares for individuals of all ages with a wide range of acute and chronic illnesses. He is especially passionate about providing high quality, evidenced-based care to underserved communities.
-
Brian Richter
Associate Director of Division Operations, Pediatrics - Hematology/Oncology
Current Role at StanfordAssociate Director of Division Operations, Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation, & Regenerative Medicine
-
Julia Rickenbacher Zhou
Office of Child Health Equity Program Manager, Pediatrics - General Pediatrics
Current Role at StanfordOffice of Child Health Equity Program Manager
-
Ashley Christine Rider
Clinical Assistant Professor, Emergency Medicine
BioDr. Ashley C. Rider is a Clinical Assistant Professor of Emergency Medicine at Stanford University School of Medicine. She earned her medical degree from Baylor College of Medicine and completed her Emergency Medicine residency at Highland Hospital in Oakland, CA. She pursued a Simulation Education fellowship at Stanford and earned a Master of Education in the Health Professions from Johns Hopkins University. She currently serves as Associate Program Director for the Stanford Emergency Medicine Residency program. Her academic interests include advancing emergency medicine education through simulation-based training, leveraging clinical data to enhance learning, and implementing quality improvement initiatives at the Graduate Medical Education (GME) level.
-
Eric Rider, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Rider is a board-certified, fellowship-trained neuromuscular neurologist with the Neuromuscular Program at the Stanford Neuroscience Health Center. He is also a clinical assistant professor in the Department of Neurology & Neurological Sciences at Stanford University School of Medicine.
Dr. Rider specializes in treating neuromuscular disease, including motor neuron disease, disorders of the neuromuscular junction, peripheral and focal neuropathies, as well as other acquired or genetic conditions that cause muscular deterioration, muscle weakness, and nerve damage. He practices both Comprehensive Neurology and Neuromuscular Medicine in Palo Alto and Emeryville.
Dr. Rider earned his medical degree at the University of California, San Francisco and completed residency at Stanford. He also completed fellowship training in Neuromuscular Medicine at UCSF. He has a passion for teaching neurology to students and patients. He was awarded the Fishers and Dunn teaching award for medical student teaching as a resident.
Dr. Rider is a member of the American Academy of Neurology and American Association of Neuromuscular & Electrodiagnostic Medicine. -
Kerri E. Rieger, MD, PhD
Clinical Professor, Pathology
Clinical Professor, DermatologyBioDr. Rieger is a Clinical Professor of Pathology and Dermatology at Stanford University. She received her M.D., Ph.D. from Stanford University School of Medicine and completed her Dermatology Residency and Dermatopathology Fellowship at Stanford University. She is board certified in Dermatology and Dermatopathology. She evaluates skin specimens in the Pathology department, where her interests include histopathologic findings in cutaneous lymphoma, hospitalized patients, and patients with autoimmune disease. She also sees patients in the Stanford dermatology clinic in Portola Valley, where her clinical interest is adult general dermatology.
